These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 149207)

  • 1. [Cellular immunity in systemic scleroderma (author's transl)].
    Hattori A
    Nihon Hifuka Gakkai Zasshi; 1978 Apr; 88(5):347-58. PubMed ID: 149207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular immune response to collagen I in patients with systemic scleroderma].
    Vladimirtsev VA; Avdeeva ZhI; Guseva NG; Rassokhina II; Anan'eva LP
    Vopr Revm; 1982; (1):33-8. PubMed ID: 6178214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scleroderma, an ageing process? I. Clinical and immunological aspects (author's transl)].
    Sandhofer M; Fritz J; Altmann H
    Aktuelle Gerontol; 1977 Dec; 7(12):645-51. PubMed ID: 26229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The state of cellular immunity in patients with systemic scleroderma].
    Borisova AM; Stepanova EN; Burnaeva ZN
    Ter Arkh; 1987; 59(4):46-8. PubMed ID: 3590004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphocyte transformation test in the scleroderma].
    Schulze P
    Dermatol Monatsschr; 1975 Jul; 161(7):547-50. PubMed ID: 1204910
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
    Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
    Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo study of cellular immunity in patients with scleroderma].
    Olszewska Z; Arkuszewska C; Płuzańska A
    Przegl Dermatol; 1984; 71(4):317-25. PubMed ID: 6515028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-elastin cellular immunity and arterial diseases. Study by leukocyte migration inhibition test].
    Leoper J; Congy F; Moulias R; Leoper J; Fichard C
    Ann Med Interne (Paris); 1977 May; 128(5):457-9. PubMed ID: 20829
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic scleroderma: a clinical and immunological study.
    Jiang SJ; Chen SL; Su LD; Yu M; Ma GP; Wang WN; Xu JB; Huang DJ; Qian YY; Gui JS
    Chin Med J (Engl); 1986 Nov; 99(11):885-92. PubMed ID: 3107926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunity in Sjögren's syndrom (author's transl)].
    Török M; Kincses E
    Klin Monbl Augenheilkd; 1977 May; 170(5):717-20. PubMed ID: 70545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell immunity in chronic hepatopathies (investigation with leucocyte migration inhibition test) (author's transl)].
    Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1978 Sep; 32(6):351-7. PubMed ID: 699087
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of HLA-B8 with visceral disease in systemic sclerosis.
    Hughes P; Gelsthorpe K; Doughty RW; Rowell NR; Rosenthal FD; Sneddon IB
    Clin Exp Immunol; 1978 Mar; 31(3):351-6. PubMed ID: 306903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.